Greg Rossi
Impact in
- Hematology top 2%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 16
- Erythropoietin and Anemia Treatment 16
- Iron Metabolism and Disorders 5
- Genetics 4
- Hemoglobinopathies and Related Disorders 4
- Co-authors
- Dianne Tomita (9 shared papers)Veena Charu (5 shared papers)Angelo Pompucci (1 shared paper)R. Roselli (1 shared paper)Massimo Scerrati (1 shared paper)Lee S. Schwartzberg (3 shared papers)Maurizio Iacoangeli (1 shared paper)John A. Glaspy (4 shared papers)
- Journals
- The Oncologist (3 papers)Blood (3 papers)Cancer (2 papers)Clinical Breast Cancer (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Greg Rossi
18 papers receiving 571 citations
Peers
Comparison fields: 5 of 43
- Hematology 456
- Genetics 149
- Biochemistry 81
- Oncology 68
- Physiology 43
Countries citing papers authored by Greg Rossi
This map shows the geographic impact of Greg Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Rossi more than expected).
Fields of papers citing papers by Greg Rossi
This network shows the impact of papers produced by Greg Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Rossi. The network helps show where Greg Rossi may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 112 | |
| 2 | 2006 | 87 | |
| 3 | 2004 | 82 | |
| 4 | 2005 | 76 | |
| 5 | 2006 | 61 | |
| 6 | 2003 | 45 | |
| 7 | 2007 | 31 | |
| 8 | 2007 | 26 | |
| 9 | 2005 | 20 | |
| 10 | 2005 | 17 | |
| 11 | A retrospective cohort study to assess the impact of therapeutic substitution of darbepoetin alfa for epoetin alfa in anemic patients with myelodysplastic syndrome. | 2006 | 16 |
| 12 | 2007 | 15 | |
| 13 | 2006 | 13 | |
| 14 | 2007 | 6 | |
| 15 | 2006 | 4 | |
| 16 | 2004 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2005 | 1 | |
| 19 | 2004 | 0 |
About Greg Rossi
Greg Rossi is a scholar working on Hematology, Genetics, Pediatrics, Perinatology and Child Health, Oncology and Biochemistry, having authored 19 papers that have together received 615 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (16 papers), Iron Metabolism and Disorders (5 papers), Hemoglobinopathies and Related Disorders (4 papers), PARP inhibition in cancer therapy (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Blood transfusion and management (2 papers) and 3D Printing in Biomedical Research (1 paper). The work is most often cited by research in Hematology (456 citations), Genetics (149 citations), Biochemistry (81 citations), Oncology (68 citations) and Physiology (43 citations). Greg Rossi has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Dianne Tomita, Veena Charu, Angelo Pompucci, R. Roselli, Massimo Scerrati, Lee S. Schwartzberg, Maurizio Iacoangeli, John A. Glaspy, Frank M. Senecal and Lorrin Yee. Their work appears in journals such as The Oncologist, Blood, Cancer, Clinical Breast Cancer and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.